☰

cached image

Richard Parad, MD, MPH - Publications

Affiliations: 
1987- Pediatric Newborn Medicine Harvard Medical School - Brigham and Women's Hospital 
Area:
newborn lung disease, cystic fibrosis, bronchopulmonary dysplasia, CF newborn screening
Website:
https://physiciandirectory.brighamandwomens.org/details/1265/richard-parad-neonatology-pediatric_medicine-boston
Tree Info Similar researchers PubMed Report error

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Green RC, Shah N, Genetti CA, Yu T, Zettler B, Uveges MK, Ceyhan-Birsoy O, Lebo MS, Pereira S, Agrawal PB, Parad RB, McGuire AL, Christensen KD, Schwartz TS, Rehm HL, et al. Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. American Journal of Human Genetics. PMID 37279760 DOI: 10.1016/j.ajhg.2023.05.007  0.31
2021 Langfelder-Schwind E, Raraigh KS, Parad RB. Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelines. Pediatric Pulmonology. PMID 34964558 DOI: 10.1002/ppul.25806  0.413
2021 Parad RB, Sheldon Y, Bhattacharjee A. Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. International Journal of Neonatal Screening. 7. PMID 34842620 DOI: 10.3390/ijns7040077  0.426
2020 Parad RB, Kaler SG, Mauceli E, Sokolsky T, Yi L, Bhattacharjee A. Targeted next generation sequencing for newborn screening of Menkes disease. Molecular Genetics and Metabolism Reports. 24: 100625. PMID 32714836 DOI: 10.1016/j.ymgmr.2020.100625  0.323
2020 Smith LD, Bainbridge MN, Parad RB, Bhattacharjee A. Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges. International Journal of Neonatal Screening. 6. PMID 32352041 DOI: 10.3390/ijns6020032  0.42
2019 Langfelder-Schwind E, Raraigh KS, Parad RB. Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen-positive diagnostic resolution process. Journal of Genetic Counseling. PMID 31550062 DOI: 10.1002/jgc4.1170  0.492
2019 Davis JM, Pilon AL, Shenberger J, Breeze JL, Terrin N, Mazela J, Gulszinka E, Lauderbach R, Parad R. The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity. Pediatric Research. PMID 31086287 DOI: 10.1038/S41390-019-0419-3  0.311
2018 Sontag MK, Sarkar D, Comeau AM, Hassell K, Botto LD, Parad R, Rose SR, Wintergerst KA, Smith-Whitley K, Singh S, Yusuf C, Ojodu J, Copeland S, Hinton CF. Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance. International Journal of Neonatal Screening. 4: 16. PMID 29862374 DOI: 10.3390/Ijns4020016  0.504
2018 Murry JB, Machini K, Ceyhan-Birsoy O, Kritzer A, Krier JB, Lebo MS, Fayer S, Genetti CA, Vannoy GE, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire AL, Green RC, et al. Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: A BabySeq Project case report. Cold Spring Harbor Molecular Case Studies. PMID 29728376 DOI: 10.1101/mcs.a002873  0.345
2017 Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, et al. Diagnosis of Cystic Fibrosis in Screened Populations. The Journal of Pediatrics. 181: S33-S44.e2. PMID 28129810 DOI: 10.1016/J.Jpeds.2016.09.065  0.827
2016 Salinas DB, Azen C, Young S, Keens TG, Kharrazi M, Parad RB. Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length. Genetic Testing and Molecular Biomarkers. PMID 27447098 DOI: 10.1089/Gtmb.2016.0102  0.727
2015 Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, Barben J, Southern KW. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 25630966 DOI: 10.1016/J.Jcf.2015.01.001  0.606
2015 Ren CL, Parad R, Borowitz D. Indeterminate cystic fibrosis newborn screening results. Pediatric Pulmonology. 50: 209-10. PMID 24760681 DOI: 10.1002/Ppul.23055  0.733
2012 Keiles S, Koepke R, Parad R, Kharrazi M. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 257-60. PMID 22209734 DOI: 10.1016/J.Jcf.2011.11.010  0.498
2011 Labrecque M, Parad R, Gupta M, Hansen A. Donation after cardiac death: the potential contribution of an infant organ donor population. The Journal of Pediatrics. 158: 31-6. PMID 20732689 DOI: 10.1016/J.Jpeds.2010.06.055  0.33
2010 Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. Journal of Inherited Metabolic Disease. 33: S255-61. PMID 20521170 DOI: 10.1007/S10545-010-9117-3  0.814
2009 Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. The Journal of Pediatrics. 155: S73-93. PMID 19914445 DOI: 10.1016/J.Jpeds.2009.09.001  0.8
2009 Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. The Journal of Pediatrics. 155: S106-16. PMID 19914443 DOI: 10.1016/J.Jpeds.2009.09.003  0.805
2009 McAnulty G, Duffy FH, Butler S, Parad R, Ringer S, Zurakowski D, Als H. Individualized developmental care for a large sample of very preterm infants: health, neurobehaviour and neurophysiology. Acta Paediatrica (Oslo, Norway : 1992). 98: 1920-6. PMID 19735497 DOI: 10.1111/J.1651-2227.2009.01492.X  0.366
2009 Nathe KE, Parad R, Van Marter LJ, Lund CA, Suter EE, Hernandez-diaz S, Boush EB, Ikonomu E, Gallington L, Morey JA, Zeman AM, Mcnamara M, Levy O. Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatric Research. 66: 191-6. PMID 19390484 DOI: 10.1203/Pdr.0B013E3181Aa33D7  0.324
2009 Carlson D, McKeen E, Mitchell M, Torres B, Parad R, Comeau AM, O'Sullivan BP. Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care. Pediatric Pulmonology. 44: 497-502. PMID 19360845 DOI: 10.1002/Ppul.21029  0.538
2008 Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. The Journal of Pediatrics. 153: S4-S14. PMID 18639722 DOI: 10.1016/J.Jpeds.2008.05.005  0.818
2008 Hale JE, Parad RB, Comeau AM. Newborn screening showing decreasing incidence of cystic fibrosis. The New England Journal of Medicine. 358: 973-4. PMID 18305279 DOI: 10.1056/NEJMc0707530  0.523
2007 Comeau AM, Accurso FJ, White TB, Campbell PW, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics. 119: e495-518. PMID 17272609 DOI: 10.1542/Peds.2006-1993  0.829
2007 O'Sullivan BP, Comeau AM, Parad R. Pulmonary Manifestations in  F508/R117H: In Reply Pediatrics. 119: 647a-648. DOI: 10.1542/Peds.2006-3532  0.621
2006 O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R. Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype. Pediatrics. 118: 1260-5. PMID 16951024 DOI: 10.1542/Peds.2006-0399  0.817
2005 Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result. The Journal of Pediatrics. 147: S98-100. PMID 16202793 DOI: 10.1016/J.Jpeds.2005.08.007  0.807
2005 Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Challenges in implementing a successful newborn cystic fibrosis screening program. The Journal of Pediatrics. 147: S89-93. PMID 16202791 DOI: 10.1016/J.Jpeds.2005.08.006  0.784
2005 Parad RB, Comeau AM. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. The Journal of Pediatrics. 147: S78-82. PMID 16202789 DOI: 10.1016/j.jpeds.2005.08.017  0.574
2005 Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP. Sweat testing infants detected by cystic fibrosis newborn screening. The Journal of Pediatrics. 147: S69-72. PMID 16202787 DOI: 10.1016/J.Jpeds.2005.08.015  0.799
2005 Wilfond BS, Parad RB, Fost N. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. The Journal of Pediatrics. 147: S109-13. PMID 16202773 DOI: 10.1016/J.Jpeds.2005.08.019  0.606
2004 Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 113: 1573-81. PMID 15173476 DOI: 10.1542/Peds.113.6.1573  0.777
2003 Parad RB, Comeau AM. Newborn screening for cystic fibrosis. Pediatric Annals. 32: 528-35. PMID 12942895  0.391
2001 Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 3: 411-5. PMID 11715005  0.789
2001 Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. The Journal of Pediatrics. 138: 198-204. PMID 11233077 DOI: 10.1067/Mpd.2001.110980  0.384
1999 Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infection and Immunity. 67: 4744-50. PMID 10456926 DOI: 10.1128/Iai.67.9.4744-4750.1999  0.537
1999 Chiba-Falek O, Parad RB, Kerem E, Kerem B. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. American Journal of Respiratory and Critical Care Medicine. 159: 1998-2002. PMID 10351951 DOI: 10.1164/Ajrccm.159.6.9808012  0.317
1999 Parad R, Nield H, Harrison E, Osterman J, Moore M. Occurrence of Hyaline Membrane Disease (HMD) in Infants ≥ 34 Weeks Gestation Is Not Explained by Carrier State for Surfactant Protein-B (SP-B) Mutation 121ins2 Pediatric Research. 45: 314A-314A. DOI: 10.1203/00006450-199904020-01867  0.339
1999 Cullen A, Van Marter LJ, Emanuel RL, Moore M, Parad R, Sunday ME. Urine Bombesin-Like Peptide as a Predictor for Bronchopulmonary Dysplasia in Infants ≤ 1 kg Pediatric Research. 45: 299A-299A. DOI: 10.1203/00006450-199904020-01777  0.31
1999 Van Marter L, Leviton A, Allred EN, Pagano M, Sanocka U, Parad R, Moore M. Clinical Markers of Barotrauma and Oxygen Toxicity and Inter-Hospital Variation in Rates of Chronic Lung Disease Among Surviving Very Low Birth Weight Infants Pediatric Research. 45: 257A-257A. DOI: 10.1203/00006450-199904020-01533  0.307
1998 Parad RB. Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement. Pediatrics. 101: 851-5. PMID 9565413 DOI: 10.1542/peds.101.5.851  0.482
1997 Davis JM, Rosenfeld WN, Richter SE, Parad R, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome Pediatrics. 100: 24-30. PMID 9200356 DOI: 10.1542/Peds.100.1.24  0.321
1996 Parad RB. Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D. Journal of Medical Genetics. 33: 711-3. PMID 8863168  0.388
1996 Feinberg E, Richardson DK, Als H, Sell E, Parad R. LATE PULMONARY OUTCOMES POORLY PREDICTED BY EARLY RISK FACTORS IN VERY LOW BIRTH WEIGHT INFANTS • 1566 Pediatric Research. 39: 263-263. DOI: 10.1203/00006450-199604001-01589  0.345
1995 Bromley B, Parad R, Estroff JA, Benacerraf BR. Fetal lung masses: prenatal course and outcome. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 14: 927-36; quiz p1378. PMID 8583529 DOI: 10.7863/Jum.1995.14.12.927  0.356
1993 Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Human Molecular Genetics. 2: 159-63. PMID 7684637  0.619
1992 Estroff JA, Parad RB, Benacerraf BR. Prevalence of cystic fibrosis in fetuses with dilated bowel. Radiology. 183: 677-80. PMID 1584918 DOI: 10.1148/radiology.183.3.1584918  0.374
Show low-probability matches.